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Objectives. We sought o directly compare the diagnostic value 
of exercise-redistribution-reinjection thallium single-photon 
emission computed tomography (SPECT) and low dose dobut- 
amine echocardiography for prediction of contractile recovery 
after revascularization. 
Background. Both thallium SPECT and dobutamine chocar- 
diography have been proposed to predict he reversibility of left 
ventricular dysfunction after revascularization. Although both 
techniques permit differentiation of viable from nonviable myo- 
cardium, few studies have directly compared their accuracy in the 
same patients. 
Methods. Seventy-three consecutive patients (mean [-SD] age 
59 -+ 9 years) with coronary disease and regional left ventricnlar 
dysfunction underwent exercise--redistribution-reinjection thal- 
lium SPECT and dobutamine chocardiography before revascu- 
larization. Recovery of function was evaluated with echocardiog- 
raphy 5.5 +-. 2.5 months after evascularization. For analysis, the 
left ventricle was divided into 16 segments, in which percent 
thallium uptake was quantitated using circumferential profiles, 
and regional wall motion was graded semiquantitatively (nor- 
mal = 1; akinetic = 3). 
Results. The diagnostic performance of the two tests was 
investigated both for individual patients and for individual seg- 
ments. Individual patient analysis showed that left ventricular 
ejection fraction improved >5% after revascularization in 43 
patients, whereas 30 showed no change. Receiver operating char- 
acteristic curves were used to select optimal criteria for prediction 
of functional recovery after revascularization. According to a 
mean thallium uptake >54% at reinjection, SPECT had a sensi- 
tivity of 72%, a specificity of 73% and an overall accuracy of 73%. 
Similarly, according to an improvement i  wall motion score >3.5 
grades during dobutamine chocardiography, eehocardiography 
had a sensitivity of 88%, a specificity of 77% and an overall 
accuracy of 84% (p = NS vs. thallium). Segmental analysis 
showed that SPECT and dobutamine echocardiography had sim- 
ilar sensitivity (77% and 75%, respectively), but SPECT had lower 
specificity (56% vs. 86%, p < 0.01). 
Conclusions. Quantitative xercise-redistribution-reinjection 
thallium SPECT and dobutamine echocardiography have compa- 
rable accuracy for prediction of reversibility of global eft ventric- 
ular dysfunction after revascularization. However, dobutamine 
echocardiography as greater specificity than thallium imaging 
for prediction of functional recovery on a segmental basis. 
(JAm CoU Cardiol 1996;28:432-42) 
Selection of patients with ischemic left ventricular dysfunction 
who would benefit from coronary revascularization requires 
the ability to differentiate dysfunctional but viable myocardium 
from irreversibly damaged and thus nonviable myocardium. 
Several modalities, including thallium imaging (1-6) and do- 
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butamine chocardiography (7-13), have been proposed to 
predict he reversibility of left ventricular dysfunction i  pa- 
tients with ischemic heart disease. Although these modalities 
share the same final purpose (i.e., to predict which segment is
likely to resume contractile function after revascularization), 
the mechanisms by which they identify reversible dysfunction 
are quite different. Thallium imaging relies mainly on the 
ability of the plasma membrane ofcardiac myocytes to actively 
take up cations, whereas dobutamine echocardiography specif- 
ically assesses the contractile reserve of the dysfunctional 
myocardium. Thus, although both tests may reflect he pres- 
ence of viable myocytes within a dysfunctional segment, hey 
address different intracellular processes and may therefore 
provide different information regarding the return of contrac- 
tile performance after revascularization (14). 
JACC Vol. 28, No. 2 VANOVERSCHELDE ET AL. 433 
August 1996:432-42 ECHOCARDIOGRAPHIC VS. SPECT MYOCARDIAL VIABILITY 
Although existing data suggest that both thallium imaging 
and dobutamine chocardiography can predict the return of 
contractile function after revascularization, few studies have 
directly compared their diagnostic accuracy in the same pa- 
tients (11,14,15). In addition, most studies performed to date 
have exclusively concentrated on predicting reversible dysfunc- 
tion on a regional basis, although clinically, the functional 
outcome of individual patients is the preferred end point. 
Accordingly, the purpose of the present study was to directly 
compare, in a large number of patients, the sensitivity, speci- 
ficity and diagnostic accuracy of exercise-redistribution- 
reinjection thallium single-photon emission computed tornog- 
raphy (SPECT) and low dose dobutamine chocardiography 
for the prediction of contractile recovery after revasculariza- 
tion on both a segmental nd an individual patient basis. 
Methods  
Study group. The study included 73 consecutive patients 
(62 men, 11 women; mean age 59 _+ 9 years, range 35 to 74) 
with ischemic heart disease and well defined coronary anat- 
omy. By reviewing all diagnostic coronary angiograms of 
patients who underwent revascularization at our institution 
between October 1991 and September 1994, we prospectively 
selected patients with severe regional dysfunction i  the ana- 
tomic distribution of a significantly narrowed or occluded 
epicardial artery. Fifty patients had a history of myocardial 
infarction, the most recent occurring 33 days before inclusion 
in the study. Patients were considered eligible for inclusion if 
they fulfilled the following criteria: 1) severe regional dysfunc- 
tion at cineventriculography; 2) suitability of the coronary 
arteries upplying the area of dysfunction for coronary artery 
bypass graft surgery or percutaneous transluminal coronary. 
angioplasty; 3) complete revascularization f the dysfunctional 
segments; 4) absence of perioperative or periprocedural myo- 
cardial infarction, defined as new-onset Q waves on the 
electrocardiogram (ECG) or a postrevascularization increase 
in plasma cardiac enzyme activity (creatine kinase, MB frac- 
tion [CK-MB] >100 IU/liter, serum glutamic oxaloaeetic 
transaminase [SGOT] >90 IU/liter); 5) adequate transthoracic 
echocardiograms for assessment of wall motion in each seg- 
ment of the left ventricle. The decision to revascularize was 
based on clinical considerations. The study protocol was 
approved by our Ethical Committee, and no complications 
resulted from any part of the study. 
Cardiac catheterization. Selective coronary arteriography 
and contrast left ventriculography were performed from the 
femoral approach before the echocardiographic and scinti- 
graphic studies. Significant coronary artery disease was defined 
as >70% lumen diameter stenosis in any major coronary 
branch. Fifty-four patients had complete occlusion of one or 
more major epicardial coronary segments (occlusion of left 
anterior descending coronary artery in 30, proximal circumflex 
artery in 14, right coronary artery in 41). The remaining 19 
patients had severe proximal stenoses of at least one major 
epicardial segment. Fifteen patients had single-vessel disease, 
23 had two-vessel disease, and 35 had three-vessel disease. 
Four patients also had stenosis of the left main coronary artery. 
Exercise-redistribntion-reinjection thallium scintigraphy. 
All patients performed a symptom-limited multistage dynamic 
bicycle exercise test during the hospital period for cardiac 
catheterization. The initial work load was set at 20 W, and 
exercise intensity was increased by 20 W each minute until 
subjective xhaustion or the appearance of symptoms (16). 
Three millicuries of thallium was injected intravenously during 
the last minute of exercise. Approximately 10 rain after com- 
pletion of the exercise test, SPECT images were obtained with 
a wide field of view rotating camera equipped with a high 
resolution, parallel-hole collimator centered on the 73- and 
164-keV photon peaks with a 20% window. The camera was 
rotated over a 180 ° arc in a circular orbit about the patient's 
thorax from a right anterior oblique angle of 40 ° to a left 
posterior angle of 40 ° at 6 ° increments for 30 s each. Redistri- 
bution images were obtained 4h after stress while the patients 
were resting. Immediately thereafter, all patients received an 
additional 1 mCi of thallium, and SPECT images were ac- 
quired 20 to 30 rain later (1-4). The exercise, redistribution 
and reinjection data were reconstructed in short-axis, vertical 
and longitudinal ong-axis views with an in-plane and z-axis 
resolutions of 13 ram, a 6.2-mm/pixel sampling and a 6.2-mm 
separation between slices. 
Dobutamine stress. All patients underwent dobutamine 
echocardiography during the same hospital period. All patients 
were allowed to take their prescribed medications, except for 
beta-adrenergic blocking agents, which were withdrawn for at 
least 48 h before the investigation. Before the test was started, 
a clinical history was recorded, a rest ECG and echocardio- 
gram were obtained, and a venous line was secured. Dobut- 
amine was then infused in 3-rain dose increments from 5 to 
40 /xg/kg body weight per rain under continuous ECG and 
echocardiographic monitoring (17). For safety reasons, in the 
first 15 patients of the study, peak dose was limited to 20/~g/kg 
per rain. As the safety profile of the test in patients with poor 
left ventricular ejection fraction became better appreciated, 
doses up to 40/zg/kg per rain were commonly used. The test 
was concluded after achievement of the peak dose, or earlier if 
the patient developed severe ischemia (either angina or im- 
pairment of left ventricular function) or experienced intolera- 
ble side effects, including hypertension (systolic blood pressure 
>250 mm Hg) or hypotension (decrease in systolic blood 
pressure >50 mm Hg vs. peak pressure or systolic blood 
pressure <100 mm Hg), ventricular arrhythmias (more than 
three consecutive premature ventricular contractions or con- 
stant bigeminy) or sustained supraventricular tachyarrhyth- 
mias. Clinical signs and ECG and echocardiographic images 
were recorded at the beginning of the study and every 3 rain 
thereafter until completion of the stress. 
Radionuclide ventriculography. Gated cardiac blood pool 
studies to assess left ventricular ejection fraction were per- 
formed in a subgroup of 33 patients by use of red blood cells 
labeled in vivo with 25 mCi of technetium-99m. Images from 
the "best septal" left anterior oblique projection were obtained 
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at rest with a small-field-of-view camera (Elscint) before and 
after revascularization, on the same day as the echocardio- 
graphic studies. Data were acquired for 250,000 counts per 
frame at 32 frames per cardiac cycle, with a 5% rate window 
tolerance. Left ventricular ejection fraction was calculated 
from the time-activity curves by use of a varying region-of- 
interest approach. 
Follow-up study. After the echocardiographic and scinti- 
graphic studies, but independent of their results, all patients 
underwent coronary revascularization. The interval from the 
scintigraphic and echocardiographic studies to coronary revas- 
cularization averaged 47 days (range 1 to 124). Bypass urgery 
was performed in 51 patients, with the use of the left internal 
mammary artery to graft the left anterior descending coronary 
artery, and coronary angioplasty was performed in the remain- 
ing 22 patients. During revascularization, an attempt was made 
to revascularize all the major branches with >70% lu- 
men diameter stenosis, independent of either tests results. 
Follow-up echocardiograms and radionuclide ventriculograms 
were obtained 5.5 -+ 2.5 months after revascularization. 
Data analysis. SPECTthallium. Thallium-201 scintigraphy 
was interpreted by experienced observers who had no knowl- 
edge of the clinical, echocardiographic and angiographic char- 
acteristics of the patients. The vertical and longitudinal long- 
axis tomograms and two short-axis, 2-pixel thick tomograms (at 
basal and midventricular levels) from the three sets of thallium 
images (stress, redistribution and reinjection) were analyzed 
quantitatively by use of circumferential profiles. Regional 
thallium uptake was assessed using the same 16 myocardial 
segments model as for two-dimensional echocardiography (12 
sectors on two short-axis tomograms and four apical sectors on 
two long-axis tomograms). An operator-defined region of 
interest was drawn around the left ventricular activity on each 
long- and short-axis cross sections. Myocardial activity was 
subdivided into six sectors emanating from the center of the 
tomograms, beginning at the intersection of the anterior and 
septal walls for the short-axis lices and proceeding counter- 
clockwise in equal arcs. Two sectors of the vertical ong-axis 
and longitudinal long-axis tomograms were attributed to the 
apex. Within each myocardial sector, the mean counts per pixel 
for the stress, redistribution and reinjection images were 
computed. Myocardial activity was further categorized as 
<50% or >50% of the maximal activity (3). Perfusion defects 
on exercise were also defined as reversible if relative thallium 
activity increased >10% on the redistribution or reinjection 
studies (4). 
Two-dimensional echocardiography. Echocardiograms were 
obtained with commercially available chocardiographic sys- 
tems by use of a 2.5- or 3.5-MHz wide-angle phased-array 
transducer with 64 or 96 channels. Images from the parasternal 
long- and short-axis and apical four- and two-chamber views 
were digitized on-line (ImageVue, Nova Microsonics). Before 
revascularization, the rest, 5- and 10-txg/kg per rain and peak 
dose stages were recorded igitally in a quad screen cine loop 
format and stored on 512-byte/sector rewritable optical disks. 
All stages were also recorded on videotape. Data of good 
quality were obtained for 68 patients (89%), but echocardio- 
grams were interpreted for all subjects. Images were inter- 
preted qualitatively in accordance with previous guidelines by 
experienced observers who had no knowledge of the angio- 
graphic and clinical data. Regional function was interpreted in
16 myocardial segments (basal, midventricular and apical 
levels of the septum and the lateral, anterior and inferior walls; 
and basal and midventricular levels of the anteroseptal nd 
posterior walls) and defined as i = normal, 2 = hypokinetic, or 
3 = akinetic (18,19). Normal wall motion was defined as 
->5 mm of endocardial excursion and obvious systolic wall 
thickening. Hypokinesia was defined as <5 mm of endocardial 
excursion and reduced wall thickening. Akinesia was defined as 
near absence of endocardial excursion or thickening. A global 
wall motion score was calculated for all stages of the dobut- 
amine stress and for the follow-up echocardiographic study by 
summing the scores of each individual segment. Left ventric- 
ular volumes and ejection fraction were obtained for each 
patient before revascularization, at rest, at the 10-/xg/kg per 
min and peak doses of dobutamine and again at the follow-up 
echocardiographic study. Left ventricular volumes at both 
end-diastole and end-systole were computed from the apical 
two- and four-chamber views by use of a standard Simpson's 
method. 
Dobutamine chocardiography. A normal segmental re- 
sponse to dobutamine was defined as a progressive nhance- 
ment in contractility during stress. Ischemia was identified by a 
stress-induced wall motion abnormality. Dysfunctional myocar- 
dium at baseline was considered responsive to dobutamine if 
wall motion score improved by at least one full grade or as 
nonresponsive if wall motion did not improve with low dose (5 
to 10 tzg/kg per min) dobutamine. 
Follow-up echocardiography and radionuclide ventriculogra- 
phy. As judged from the comparison of rest regional wall 
motion before and after revascularization with echocardiogra- 
phy, dysfunctional myocardium was considered to have im- 
proved functionally if the wall motion score improved by at 
least one full grade after revascularization, orto be persistently 
dysfunctional if the wall motion score did not improve after 
revascularization. Because indexes of global left ventricular 
function, such as ejection fraction and end-systolic volume, are 
important prognostic indicators in patients with ischemic left 
ventricular dysfunction (20,21), functional recovery was also 
defined on an individual patient basis. Patients were consid- 
ered to have improved left ventricular function if global 
ejection fraction increased >5% from the baseline to the 
follow-up echocardiograms or radionuclide ventriculograms. 
Statistical analysis. Continuous variables are expressed as 
mean value _+ SD. Two-way analysis of variance for repeated 
measures was used to assess differences incontinuous variables 
between patients with and without evidence of reversible 
dysfunction. The chi-square test was used to assess differences 
in categoric variables. All tests were two-tailed, and p > 0.05 
was considered indicative of a statistically nonsignificant dif- 
ference. The sensitivity, specificity and accuracy of exercise- 
redistribution-reinjection thallium SPECT and dobutamine 
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Figure 1. Pie chart showing the distribution of akinetic segments 
according to preoperative thallium (T1) SPECT and dobutamine (Db) 
echocardiography. 
echocardiography were obtained in the usual manner. The 
ability of the tests to predict functional recovery in the different 
coronary vascular territories was assessed by ascribing the 
septum and the anteroseptal nd anterior walls to the left 
anterior descending coronary artery, the lateral wall to the 
circumflex artery and the inferior wall to the right coronary 
artery. Because of the varying vascular supply of the apex, this 
was allocated to any other involved territory. If the apex alone 
was involved, the left anterior descending coronary artery was 
imputed. Likewise, the posterior wall was ascribed to either 
the right or the circumflex territory if either was involved. If the 
posterior wall alone was involved, it was ascribed to the 
circumflex artery. Results were compared by the McNemar test 
for paired data. Empiric receiver operating characteristic 
(ROC) curves were also generated to compare the accuracy of 
dobutamine chocardiography and thallium imaging in pre- 
dicting the return of global eft ventricular function in individ- 
ual patients. The ROC curves were fitted using a computer 
program based on least-square estimates of nonlinear variables 
(22). The area under the fitted curves was calculated using the 
method of trapezoids, and a z test was applied to compare the 
areas under the curves (22). A Z value >1.96 was considered 
statistically significant. 
Resul ts  
Preoperative data. A total of 1,168 segments (16/patient) 
were analyzed, of which 444 showed akinesia, 248 showed 
hypokinesia, nd 476 were normal. 
Exercise-redistribution-reinjection thallium SPECT. All pa- 
tients successfully completed the symptom-limited bicycle ex- 
ercise protocol. Immediately on exercise completion, thallium 
uptake in the akinetic segments averaged 45 _+ 19%. It 
subsequently increased to 51 __ 18% after 4 h of redistribution 
and to 53 _+ 18% after reinjection. Before revascularization, a 
regional thallium uptake >50% was noted in 173 initially 
akinetic segments after exercise, in 224 aldnetic segments after 
redistribution and in 252 akinetic segments at reinjection. 
Figure 1 shows the distribution of akinetic segments according 
to preoperative thallium SPECT and dobutamine chocardi- 
ography. Among the 252 akinetic segments with >50% thal- 
lium uptake at reinjection, 127 (50%) also improved function 
on stimulation with dobutamine. In contrast, among the 192 
initially akinetic segments with <50% thallium uptake at 
reinjection, only 36 (19%) responded to dobutamine by in- 
creasing function. 
Dobutamine chocardiography. All patients uccessfully un- 
derwent he standard staged dobutamine protocol. As men- 
tioned earlier, for safety reasons, in the first 15 patients the 
peak dose was limited to 20/xg/kg per rain. In the remaining 58 
patients, the mean dose at the peak stage or stress portion of 
the protocol was 30 ~- 10/xg/kg per rain (range 10 to 40). End 
points for this stage were achievement of maximal dose in 24 
patients, arrhythmias in 14, chest pain in 3, induction of wall 
motion abnormalities in a remote area in 4, hypotension i 9, 
hypertension i  1 and dyspnea in 3. Infusion of low dose 
dobutamine (10 t~g/kg per rain) resulted in minor changes in 
rate-pressure product (+18%). At peak dose, the rate- 
pressure product averaged 15,107 mm Hg × beats/rain (153% 
of baseline). 
During dobutamine infusion, 163 of 444 initially akinetic 
segments howed improved function, and 281 remained se- 
verely dysfunctional. Although both types of segments showed 
a significant increase in thallium uptake between stress and 
reinjection, those responding to dobutamine had a greater 
level of thallium uptake at reinjection than those with persis- 
tent dysfunction (61 _+ 15% vs. 48 _+ 17%, p < 0.001). Among 
the 163 dobutamine-responsive egments, 127 (78%) displayed 
>50% thallium uptake at reinjection. Among the 281 dobut- 
amine nonresponsive segments, 124 (44%) also had >50% 
thallium uptake at reinjection. 
Preoperative delineation of reversible dysfunction. En- 
hancement of regional left ventricular function is not the 
principal goal of intervention, which aims to improve global 
left ventricular function. Yet, many previous reports have 
identified viable myocardium solely on the basis of an improve- 
ment in regional wall motion. The present study therefore 
investigated the determinants of the return of left ventricular 
function after revascularization  both a segmental and a 
global basis. 
Delineation of reversible dysfunction on a regional basis. 
Among the 444 initially akinetic segments, 167 showed im- 
proved contractile function after revascularization. Likewise, 
among the 248 initially hypokinetic segments, 100 resumed 
normal function after revascularization. 
EXERCISE-REDISTRIBUTION-REINJECTION THALLIUM SPECT. 
Reversible dysfunction on thallium scintigraphy was deter- 
mined according to usual criteria. Figure 2 shows the results in 
both initially akinetic and hypokinetic segments. Among the 
167 initially akinetic segments with improved function after 
revascularization, thallium uptake increased >10% between 
exercise and redistribution or reinjection in 82 (57%) and was 
>50% at reinjection in 129 (77%). In the 277 akinetic seg- 
ments that remained dysfunctional after revascularization, 
thallium uptake increased <10% in 187 (68%) between exer- 
cise and redistribution or reinjection and was <50% at rein- 
jection in 155 (56%). Overall accuracy for the >10% redistri- 
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Figure 2. Bar graph showing sensitivity (SENS), specificity 
(SPEC) and accuracy (ACC) of thallium SPECT (>50% 
uptake at reinjection, solid bars) and low dose dobutamine 
echocardiography ( atched bars) for prediction of reversible 
dysfunction i akinetic (left panel) and hypokinetic (right 
panel) segments. ***p < 0.001. 
bution and >50% uptake criteria was 58% and 64%, 
respectively. Similar results (sensitivity 73%, specificity 55%, 
accuracy 66%) were obtained by using individual changes in 
global wall motion score to account for possible intrapatient 
correlations in segmental response. The diagnostic accuracy of 
thallium was similar among the different vascular territories 
(Fig. 3) and lower in hypokinetic than in akinetic segments 
(Fig. 2). 
DOBUTAMINE ECHOCARDIOGRAPHY. Among the 167 akinetic 
segments with improved function after revascularization, 127 
(76%) had a positive response to preoperative dobutamine. 
Among the 277 dysfunctional segments hat remained ysfunc- 
tional after revascularization, 239 (86%) showed no response 
to preoperative dobutamine stress. Similar results (sensitivity 
84%, specificity 76%, accuracy 81%) were obtained by using 
individual changes in global wall motion score to account for 
possible intrapatient correlations in segmental response. The 
overall diagnostic accuracy of the test did not improve with 
further dose increases. On the contrary, sensitivity decreased 
in a dose-dependent manner as the number of deteriorating 
segments increased. As shown in Figure 3, the dobutamine t st 
was equally effective in differentiating reversible from irrevers- 
ible dysfunction in the different vascular territories. As with 
thallium SPECT, the accuracy of dobutamine chocardiogra- 
phy was lower in hypokinetic than akinetic segments (Fig. 2). 
Delineation of reversible dysfunction on an individual patient 
basis. Because indexes of global eft ventricular function, such 
as ejection fraction and end-systolic volume, are important 
prognostic indicators in patients with ischemic left ventricular 
dysfunction (20), the diagnostic performance ofboth tests was 
also investigated on an individual patient basis. According to 
the changes in global ejection fraction before and after revas- 
cularization, the patients were classified into two groups: group 
1 (improvement) = 43 patients with a >5% increase in ejection 
fraction (+12 + 6%); and group 2 (no improvement) = 30 
patients with variable changes in ejection fraction (2 with no 
change, 7 with improvement <5%, 21 with deterioration). 
Before revascularization, the clinical and angiographic data were 
similar in both groups of patients (Table 1). The changes in left 
ventricular function resulting from coronary revascularization are 
also shown in Table 1. A significant correlation was observed 
between the changes in global wall motion score and those in 
either global ejection fraction (r = -0.81, p < 0.001) or end- 
systolic volume (r = 0.75, p < 0.001) after revascularization. 
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Figure 3. Bar graph showing sensitivity (SENS), 
specificity (SPEC) and accuracy (ACC) of thallium 
SPECT (left panel) and low dose dobutamine echo- 
cardiography (right panel) for identification of re- 
versible dysfunction i  the three vascular territories. 
Solid bars = left anterior descending coronary 
artery; open bars = circumflex coronary artery; 
hatched bars = right coronary artery. 
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Table 1. Clinical, Angiographic and Functional Data Before and 
After Revascularization 
Group 1 Group 2 
(improvement) (no improvement) 
(n = 43) (n = 30) p Value 
Age (yr) 59 -+ 9 58 _+ 9 NS 
Male/female 36/7 28/2 NS 
CCS angina class 
I/iI 33 (77%) 22 (73%) 
III/IV 10 (23%) 8 (27%) NS 
NYHA functional class 
I/II 37 (86%) 21 (70%) NS 
III/IV 6 (14%) 9 (30%) NS 
Previous Q wave MI 27 (63%) 23 (77%) NS 
Diseased vessel 
LAD 8 (19%) 4 (13%) NS 
Cx or RCA 3 (7%) 0 (0%) NS 
LAD+Cx 5 (11%) 1 (3%) NS 
LAD+RCA 10 (23%) 5 (17%) NS 
Cx+RCA 1 (2%) 1 (3%) NS 
LAD+Cx+RCA i6 (37%) 19 (63%) NS 
EDV (ml) 
Before 176 _+ 51 227 ± 56 <0.001 
After 164 _+ 49 233 ± 55 - -  
ESV (ml) 
Before 116 ± 49 149 _+ 54 <0.01 
After 87 ± 43 163 ± 56 - -  
EF (%) 
Before 36 _+ 12 36 _+ 12 NS 
After 49 _+ 12 32 _+ 12 - -  
WMS 
Before 31 _+ 6 33 ± 6 NS 
After 24 _+ 6 34 _+ 6 - -  
Data presented are mean value ± SD or number (%) of patients. No 
statistical nalysis was applied to the differences inleft ventricular function after 
revascularization, which are inherent in the study design. CCS = Canadian 
Cardiovascular Society; Cx = circumflex coronary artery; EDV = end-diastolic 
volume; EF = ejection fraction; ESV = end-systolic volume; LAD = left 
anterior descending coronary artery; MI = myocardial infarction; NYHA = New 
York Heart Association; RCA = right coronary artery; WMS = global wall 
motion score. See text for definition of groups. 
EXERCISE-REDISTRIBUTION-REINJECTION THALLIUM SPECT. 
Before revascularization, no difference in exercise capacity, 
maximal heart rate, rate-pressure product or exercise-induced 
ST segment changes was noted between the two groups (Table 
2). Patients with improved postoperative function had a 
greater number of dysfunctional segments with >50% thallium 
uptake and a higher mean thallium uptake at reinjection in the 
dysfunctional area. Empiric ROC curves were used to select 
the optimal cutoff criteria for prediction of the return of left 
ventficular ejection fraction after revascularization (Fig. 4). 
Their diagnostic performance is summarized in Table 3. 
DOBUTAMINE ECHOCARDIOGRAPHY. During preoperative do- 
butamine stress, the mean peak dobutamine dose was not 
different among patients with (27 _+ 10/xg/kg per rain) and 
without (29 _ 11/~g/kg per rain) postrevascularization func- 
tional improvement. The effects of incremental doses of do- 
butamine on hemodynamic variables and regional and global 
Table 2. Exercise and Thall ium SPECI" Data 
Group 1 Group 2 
(improvement) (no improvement) 
(n = 43) (n = 30) p Value 
Max work load (W) 129 _+ 38 119 _+ 38 NS 
Max HR (beats/min) 129 _+ 22 129 _+ 17 NS 
Max RPP (ram Hg × 22,026 + 7,221 21,395 -- 5,444 NS 
beats/rain) 
Exercise angina 6 7 NS 
ST segment changes 15 9 NS 
% Tl uptake in 
dysfunctional rea 
Exercise 51 + 12 42 _+ 11 < 0.01 
Redistribution 55 ± i1 48 + 11 < 0.01 
Reinjection 59 2 10 48 + 11 < 0.001 
% dysfunctional segments 
with >50% uptake 
Exercise 49 + 30 35 _+ 26 NS 
Redistribution 61 + 29 43 _+ 31 < 0.01 
Reinjection 71 ± 24 47 ± 32 < 0.001 
Data presented are mean value -~ SD or number of patients. HR = heart 
rate; Max = maximal; RPP = rate-pressure product; TI = thallium. 
left ventricular function in the two groups of patients are 
shown in Table 4. Global wall motion score improved to a 
greater extent with low dose dobutamine in patients with 
improved postoperative l ft ventricular ejection fraction (6.3 -+ 
3.0 vs. 1.1 + 3.6 grades, p < 0.001). In patients with persistent 
postoperative dysfunction, most improvement occurred in pre- 
viously hypokinetic segments, whereas both akinetic and hypo- 
kinetic segments improved in patients with an increased post- 
operative ejection fraction. No further improvement in wall 
motion was achieved with additional dose increments. Forty- 
seven patients experienced worsening of wall motion at higher 
doses. In 23 patients, deterioration occurred in remote, initially 
normally contracting segments (remote ischemia). In 33 pa- 
tients, deterioration occurred in previously dysfunctional seg- 
ments that had improved with low dose dobutamine. As shown 
in Figure 5, a significant correlation was found between 
Figure 4. Empiric receiver operating characteristic curves generated 
for selected thallium SPECT and dobutamine echocardiographic 
criteria: mean percent thallium uptake at reinjection in the dysfunc- 
tional area (b), percent dysfunctional rea with >50% thallium uptake 
(c) and degree of improvement in global wall motion score at 10 p~g/kg 
per min of dobutamine (a). 
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Table 3. Diagnostic Accuracy of Exercise-Redistribution-Reinjection Thallium SPECT and Low Dose 
Dobutamine Echocardiography for Prediction of Postrevascularization Improvement in Left 
Ventricular Ejection Fraction 
Method Sensitivity. Specificity Accuracy PPV NPV 
TI SPECT 
% segments with >50% TI uptake 72% 7(1% 71%* 78% 64% 
Mean dysfunctional TI uptake >50% 77% 60% 70%* 73% 64% 
Mean dysfunctional T1 uptake >54% 72% 73% 73% 80% 65% 
Dobutamine cho 
Improvement i  WMS >3.5 grades 88% 77% 84% 84% 82% 
*p < 0.05 versus dobutamine echocardiography (echo). NPV = negative predictive value; PPV = positive predictive 
value; SPECT = single-photon emission computed tomography; T1 = thallium; WMS = wall motion score. 
changes in global wall motion score with low dose dobutamine 
and those after revascularization. 
As with thallium SPECT, ROC curves were used to deter- 
mine the optimal cutoff criteria for identification of reversible 
dysfunction with dobutamine chocardiography. By consider- 
ing a decrease >3.5 grades in global wall motion score as 
predictive of postoperative functional recovery, dobutamine 
echocardiography allowed correct prediction in 88% of pa- 
tients with and 77% of those without postoperative functional 
improvement. Overall accuracy was 84% (p = 0.054 vs. percent 
thallium uptake; p < 0.01 vs. percent dysfunctional rea with 
>50% thallium uptake) (Table 3). Use of radionuclide ven- 
triculography rather than echoeardiograpby to define postop- 
erative functional recovery did not alter the results (Table 5). 
Subgroup analysis in patients with -<35% ejection fraction. 
Because identification of reversible l ft ventricular dysfunction 
is most important in patients with a low left ventricular ejection 
fraction, a subgroup analysis was performed in the 43 patients 
with a left ventricular ejection fraction <-35%. In these pa- 
tients, 322 segments were akinetic before revascularization, of
which 101 improved after revascularization. Prerevasculariza- 
tion thallium SPECT correctly identified 75% of the segments 
that improved after revascularization a d 55% of those that 
remained ysfunctional. Overall accuracy was 61%. Prerevas- 
cularization dobutamine chocardiography allowed correct 
prediction in 73% of the segments that improved after revas- 
cularization and in 87% of those that remained ysfunctional 
(p < 0.01 vs. thallium). Overall accuracy was 83% (p < 0.01 vs. 
thallium). The diagnostic performance of both tests was also 
investigated on an individual patient basis (Table 6). Twenty- 
three patients had improved ejection fraction after revascular- 
ization, whereas the remaining 20 had persistent dysfunction. 
Empiric ROC curves were used to select the optimal cutoff 
criteria for prediction of the return of left ventricular ejection 
Table 4. Hemodynamic and Segmental Response to Infusion of Dobutamine 
Low Dose Peak Dose (28 ± 
Baseline (10/Lg/kg per rain) 10/xg/kg per min) 
HR (beats/min) 
Improvement 75 ± 14 83 ± 21 114 ± 22 
No improvement 72 ± 14 79 _+ 15 103 ± 28 
BP (mm Hg) 
Improvement 103 ± 14 107 -+ 13 103 -+ 17 
No improvement 104 _+ 14 105 -+ 15 100 --_ 18 
RPP (mm Hg × heats/min) 
Improvement 9,993 _+ 2,526 12,020 ± 4,073 15,917 2 4,762 
No improvement 9,754 _+ 2,191 11,298 ± 2,702 14,037 ~ 4,134 
EDV (ml) 
Improvement 176 ± 51 161 ± 50 151 ± 54 
No improvement 227 ± 56* 217 +_ 57* 206 ± 63* 
ESV (ml) 
Improvement 116 _+ 49 81 ± 40 83 ± 45 
No improvement 149 ± 54t 138 _+ 57* 132 ± 60* 
EF (%) 
Improvement 36 ± 12 52 ± 12 46 ± 16 
No improvement 36 ± 12 39 ± 14" 39 ± 15 
WMS 
Improvement 31 ± 6 24 _+ 5 29 2 7 
No improvement 33 ± 6 32 -+ 6* 33 + 65 
*p < 0.001, tp < 0.01, Sp < 0.05, improvement versus no improvement. Data presented are mean value + SD. 
Abbreviations as in Tables 1 and 2. 
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Figure 5. Scatterplot showing correlation of changes in global wall 
motion score (RWMS) during low dose dobutamine (DOBU) with 
those observed after revascularization (RVS). 
fraction after revascularization. According to a mean thallium 
uptake >54% at reinjection, SPECT had a sensitivity of 65%, 
a specificity of 70% and an overall accuracy of 67%. Similarly, 
according to an improvement in wall motion score by >3.5 
grades during dobutamine chocardiography, echocardiogra- 
phy had a sensitivity of 87%, a specificity of 70% and an overall 
accuracy of 79% (p = NS vs. thallium). 
Discussion 
Various approaches, including thallium imaging (1-6), 
positron emission tomography (23-27) and, more recently, low 
dose dobutamine chocardiography (7-15), have been pro- 
posed for prediction of reversibility of left ventricular dysfunc- 
tion after coronary revascularization. Although each technique 
permits differentiation of reversible from irreversible myocar- 
dial injury, few available data directly compare their relative 
accuracy in the same patients (7,11,14,15). In the present study, 
we therefore sought o evaluate the relative merits of exercise- 
redistribution-reinjection thallium scintigraphy and low dose 
Table 5. Diagnostic Accuracy of F.xercise-Redistribution- 
Reinjection Thallium SPECT and Low Dose Dobutamine 
Echocardiography in 33 Patients Undergoing 
Radionuclide Ventriculography 
Method Sensitivity Specificity Accuracy 
Viability by echo 
Improvement in WMS 100% 79% 91% 
>3.5 grades 
Mean dysfunctional TI 68% 79% 73% 
uptake >54% 
Viability by radionuelide 
ventriculography 
Improvement in WMS 100% 71% 85% 
>3.5 grades 
Mean dysfunctional TI 75% 76% 76% 
uptake >54% 
Abbreviations as in Table 3. 
dobutamine chocardiography for prediction of reversible 
dysfunction in a large consecutive series of patients with 
chronic left ventricular ischemic dysfunction undergoing revas- 
cularization. After revascularization, functional improvement 
was noted in 37% of initially akinetic segments and in 40% of 
initially hypokinetic segments. On an individual patient basis, 
functional recovery (defined as a >5% increase in left ventric- 
ular ejection fraction) was noted in 43 patients (59%) and was 
clearly associated with the return of regional contractile per- 
formance. The predictive accuracy of exercise-redistribution- 
reinjection thallium SPECT and dobutamine chocardiogra- 
phy was tested against he return of both regional (segmental 
analysis) and global (patient analysis) left ventricular function. 
Delineation of reversible dysfunction on a regional basis. 
Before revascularization, a greater number of segments 
showed evidence of viability by thallium than by dobutamine 
echocardiography (64% vs. 37%). Similar findings have been 
reported previously by other investigators. Comparing the 
results of exercise-redistribution-reinjection thallium SPECT 
and low dose dobutamine echocardiography in 30 patients with 
ischemic left ventricular dysfunction, Panza et al. (14) showed 
that the number of dysfunctional segments with preserved 
thallium uptake significantly exceeded the number of segments 
with residual inotropic reserve (54% vs. 30%). Recently, 
Arnese et al. (15) also reported that thallium SPECT indicates 
residual viability more frequently than dobutamine echocardi- 
ography (61% vs. 20%). Taken together, our findings, as well 
as those of Panza et al. and Arnese et al., could thus indicate 
that the myocardial processes necessary to maintain thallium 
uptake are less sensitive to the deleterious consequences of 
coronary artery disease than to those responsible for the 
inotropic response to dobutamine (14). It is indeed likely that 
the maintenance of cell viability more critically depends on a 
preserved transmembrane pump activity than on a maintained 
inotropic reserve. Accordingly, some investigators have pro- 
posed the presence of a spectrum of myocardial dysfunction i
patients with coronary disease whereby mild myocyte dysfunc- 
tion would be characterized by both a preserved membrane 
integrity and the capacity to respond to an inotropic stimulus, 
and in more severe reversible dysfunction, the capacity to 
respond to inotropic stimuli would be lost, despite a persis- 
tently normal membrane function (14). Accordingly, the higher 
prevalence of viable segments detected by thallium SPECT as 
opposed to dobutamine chocardiography would indicate the 
greater capacity of thallium to predict potentially reversible 
dysfunction. It should be emphasized, however, that only the 
serial measurement of mechanical function after revasculariza- 
tion allows determination of the reversibility or irreversibility 
of injury. We therefore compared the results of thallium 
SPECT and dobutamine chocardiography with those of the 
functional assessment performed 5 months after revasculariza- 
tion (all analyzed in the same format) and found that although 
both methods had comparable sensitivity for identification of 
reversible dysfunction, thallium SPECT, in fact, overestimated 
the amount of salvageable myocardium, resulting in a low 
specificity and a low positive predictive accuracy. These results 
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Table 6. Diagnostic Accuracy of Exercise-Redistribution-Reinjection Thallium SPECT and Low Dose 
Dobutamine Echocardiography in 43 Patients With Left Ventricular Ejection Fraction <35% 
Method Sensitivity Specificity Accuracy PPV NPV 
T1 SPECT 
% segments with >50% T1 uptake 61% 70% 65% 70% 61% 
Mean dysfunctional TI uptake >50% 65% 60% 63% 65% 60% 
Mean dysfunctional T1 uptake >54% 65% 70% 67% 71% 63% 
Dobutamine cho 
Improvement i  WMS >3.5 grades 87% 70% 79% 77% 82% 
Abbreviations as in Table 3. 
are consistent with those of several previous tudies evaluating 
the accuracy of thallium for the prediction of the return of 
contractile function after revascularization. Although these 
studies varied widely in terms of imaging protocols and criteria 
used to define positivity, many reported low specificity 
(2,5,15,28,29). 
Conventional dobutamine chocardiographic protocols 
are increasingly used for the identification of residual 
myocardial viability early (<2 weeks) after myocardial in- 
farction (7-11). Although the dobutamine t st is successful 
in predicting reversible dysfunction in the setting of acute 
myocardial infarction, fewer data are available to support i s 
efficacy in patients with chronic left ventricular ischemic 
dysfunction ("chronic myocardial hibernation") (12-15,30). 
In contrast to the early postinfarction period, where stunned 
myocardium is probably predominant, chronic myocardial 
hibernation most likely involves both postischemic dysfunc- 
tion and ongoing reduction of myocardial blood flow. It is 
known to be associated with marked ultrastructural lter- 
ations in the myocytes, including a loss of myofilaments and 
contractile material (31-33), and with no or a very limited 
residual coronary flow reserve (31). Chronically dysfunc- 
tional but hibernating myocardium ay therefore be less 
responsive to inotropic stimulation than purely stunned 
myocardium. However, there is increasing evidence that low 
dose dobutamine echocardiography permits accurate pre- 
diction of the reversibility of dysfunction in chronically 
hibernating myocardium as well. In a study of 25 patients 
undergoing coronary revascularization, Cigarroa et al. (12) 
showed that a >20% improvement i  systolic wall thicken- 
ing score during dobutamine had a sensitivity of 82% and a 
specificity of 86% for recovery at follow-up. Similar results 
(87% sensitivity and 82% specificity) were recently reported 
by La Canna et al. (13), for 33 selected patients under- 
going bypass surgery, as well as by other investigators 
(14,15,30,34). 
The present findings confirm and extend those previous 
reports. Of the 167 initially akinetic segments resuming 
contractile function after revascularization, 76% responded 
to preoperative dobutamine infusion by increased function. 
Similarly, of the 277 dysfunctional segments that remained 
abnormal after revascularization, 86% failed to show im- 
proved function during low dose dobutamine infusion. 
However, the specificity of the test was lower in hypokinetic 
than akinetic segments (68%). There are several potential 
reasons for the poor specificity of the dobutamine t st in 
hypokinetic segments. Segmental hypokinesia may reflect 
the presence of a subendocardial scar and may be unaffected 
by revascularization. Nonetheless, if enough noninfarcted 
myocardium remains in mid and epicardial ayers, such 
segments could still manifest improvement with dobut- 
amine. Tethering by adjacent akinetic segments could also 
be an explanation. In this case, the segmental response to 
revascularization will largely depend on the recovery of the 
adjacent segments, whereas the response to dobutamine will 
also reflect he changes in segmental contractility, cavity size 
and afterload. 
Delineation of reversible dysfunction on an individual 
patient basis. Although it is important to consider the diag- 
nostic performance of tests aimed at predicting reversible 
dysfunction on a regional basis, clinically, the functional out- 
come of individual patients i  obviously a preferred end point. 
Indexes of global eft ventricular function, such as ejection 
fraction and end-systolic volume, have indeed been shown to 
be important prognostic indicators in patients with ischemic 
left ventricular dysfunction (20). Accordingly, in the present 
study, we also investigated the diagnostic performance of 
thallium SPECT and dobutamine echocardiography for pre- 
dicting the improvement i  global eft ventricular function in 
individual patients. Of the 73 patients included in our study, 43 
demonstrated an improvement in left ventricular ejection 
fraction >5% after revascularization. The remaining 30 pa- 
tients showed no or minimal changes. Empiric ROC curves 
were used to select he optimal SPECT and echocardiographic 
variables eparating patients with and without postoperative 
functional improvement and to evaluate the relative merits of 
the selected variables in predicting the return of global eft 
ventricular function after revascularization. Two SPECT (pro- 
portion of dysfunctional segments with >50% thallium uptake 
at reinjection and mean thallium uptake at reinjection in the 
dysfunctional area) and one echocardiographic (improvement 
in global wall motion score during low dose dobutamine) 
variables were selected and evaluated. Each of these variables 
showed reasonable accuracy (Table 3). 
Study limitations. The present study has several limita- 
tions: 1) Because the extent of coronary revascularization was 
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not assessed in each patient, we cannot dismiss the possibility 
that early graft closure or restenosis prevented the recovery of 
otherwise viable segments and thereby influenced specificity. 
However, in those patients who were prospectively followed up 
angiographically after revascularization (data not shown), 
these events were rare, and can thus be expected to be rare in 
the group as a whole. 
2) Because left ventricular ejection fraction is an important 
prognostic indicator in patients with left ventricular dysfunc- 
tion undergoing revascularization, weused this variable in our 
patient-based definition of myocardial viability. It is therefore 
possible that some of the changes noted after evascularization 
were not related to the revascularization procedure itself but 
resulted from changes in the loading conditions or in medical 
treatment, or both. This possibility is unlikely, however, be- 
cause the changes in global left ventricular function observed 
in our study did not parallel those in either mean arterial 
pressure, left ventricular end-diastolic volume (used as rough 
measures of afterload and preload) or medical treatment 
(which mainly included nitrates and angiotensin-converting 
enzyme inhibitors both before and after evascularization) and 
were always attended by similar directional changes in regional 
wall motion. 
3) We used the postoperative improvement in left ventric- 
ular function as the outcome measurement for patient selec- 
tion, although relief of anginal symptoms and actuarial survival 
are usually the preferred end points. The present study did not 
have the statistical power to address the effects of revascular- 
ization on either symptoms or survival in any meaningful way. 
We therefore relied on evaluation of the response of left 
ventricular function to revascularization, which was recently 
shown to be intimately related to long-term prognosis (21). 
Although the results of the present study suggest that evalua- 
tion of residual thallium uptake and inotropic reserve are 
useful predictors of the return of left ventricular function after 
revascularization, further studies will be necessary to address 
their relative impact on the long-term prognosis of patients 
with advanced coronary artery disease and left ventricular 
dysfunction. 
Conclusions. The present study evaluated the relative mer- 
its of exercise-redistribution-reinjection thallium SPECT and 
low dose dobutamine echocardiography for the prediction of 
the return of regional and global eft ventricular function after 
revascularization. The data indicate that both techniques have 
comparable accuracy for prediction of the reversibility of 
global left ventricular dysfunction after revascularization a d 
that dobutamine echocardiography hasgreater specificity than 
thallium imaging for prediction of functional recovery on a 
segmental basis. 
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